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Abstract
West Nile virus (WNV) is a blood-borne pathogen that causes systemic infections and serious neurological disease in human
and animals. The most common route of infection is mosquito bites and therefore, the virus must cross a number of
polarized cell layers to gain access to organ tissue and the central nervous system. Resistance to trans-cellular movement of
macromolecules between epithelial and endothelial cells is mediated by tight junction complexes. While a number of recent
studies have documented that WNV infection negatively impacts the barrier function of tight junctions, the intracellular
mechanism by which this occurs is poorly understood. In the present study, we report that endocytosis of a subset of tight
junction membrane proteins including claudin-1 and JAM-1 occurs in WNV infected epithelial and endothelial cells. This
process, which ultimately results in lysosomal degradation of the proteins, is dependent on the GTPase dynamin and
microtubule-based transport. Finally, infection of polarized cells with the related flavivirus, Dengue virus-2, did not result in
significant loss of tight junction membrane proteins. These results suggest that neurotropic flaviviruses such as WNV
modulate the host cell environment differently than hemorrhagic flaviviruses and thus may have implications for
understanding the molecular basis for neuroinvasion.
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Introduction
West Nile virus (WNV) is a blood-borne pathogen that can
cause serious systemic and neurological disease in human and
animals. In order for this to occur, the virus must cross multiple
polarized cell layers after mosquito borne transmission. Resistance
to movement of macromolecules and pathogens across epithelia
and endothelia is mediated in large part by tight junctions. The
latter are apically located protein complexes which are composed
of integral membrane proteins including claudins, occludins and
junctional adhesion molecules (JAM) that form intracellular
interactions with cytoplasmic components such as ZO-1, ZO-2,
ZO-3 and the actin cytoskeleton (reviewed in [1]). Homotypic
interactions between claudins, occludins and JAMs on apposing
cells constitute the main barrier to intercellular passage of
macromolecules. Tight junctions are highly dynamic and para-
cellular permeability can be affected by a variety of physiological
and pathological conditions. With respect to the latter, it is thought
that the pathogenicity of notable human viruses such as severe
acute respiratory coronavirus, influenza and ebola viruses is
related to their abilities to negatively impact the barrier function of
tight junctions [2,3,4]. Interestingly, each of these viruses interferes
with tight junctions through different mechanisms.
A number of recent in vitro and in vivo studies have focused on
how WNV crosses polarized cell layers but the collective findings
do not agree with respect to the underlying mechanism. For
example, one group reported that expression of capsid protein
inhibits the barrier function of tight junctions by inducing
degradation of claudin proteins in lysosomes [5]. In contrast,
Verma et al report that infection of endothelial cells by WNV per se
does not reduce levels of tight junction components, but rather,
matrix metalloproteases that are secreted from infected astrocytes
cause breakdown of these structures [6,7]. Moreover, they indicate
that WNV infection actually results in a small but significant
increase in claudin-1 levels. Finally, data from another laboratory
which conducted pathogenesis studies in mice, support a role for
matrix metalloproteinase 9 in WNV-induced disruption of the
blood brain barrier through degradation of basement membranes
[8]. However, the effects of viral infection on tight junction
components were not investigated in this study.
For the first time, we employed a coordinated study to
understand the effects of WNV infection on tight junction proteins
in both epithelial and endothelial cells. Our findings indicate that
WNV infection results in targeted endocytosis of a specific subset
of tight junction membrane proteins followed by microtubule-
dependent transport to and degradation in lysosomes. However, in
contrast to Medigeshi et al [5], we observed that capsid protein
expression alone did not result in degradation of tight junction
integral membrane proteins.
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WNV infection results in degradation of a subset of tight
junction membrane proteins
Published studies documenting the effects of WNV infection on
tight junction complexes are not in agreement. Some of the
discrepancies may be due to the fact that one study employed
epithelial cells [5] whereas others used endothelial cells [6,7]. To
determine if the published data vary due to cell type specific
differences, we analyzed the effects of WNV infection on tight
junctions in a number of well characterized epithelial and
endothelial cell lines. Data in Figure 1 show that in all cases, the
tight junction membrane proteins claudin-1 and JAM-1 are
degraded in WNV infected cells. In contrast, levels of occludin
protein were unaffected.
Lysosomal degradation [5] and matrix metalloproteases [6,7]
have been implicated in WNV-induced turnover of tight junction
proteins. However, because a large pool of the WNV capsid
protein is targeted to the nuclei of infected cells [9,10],
transcription of claudin-1 and JAM-1 genes could also be affected
by WNV replication. Therefore, we used RT-PCR to assess the
relative levels of tight junction-specific mRNAs in WNV-infected
cells. Data in Figure 2 indicate that WNV infection does not
decrease the levels of claudin-1- or JAM-1-specific or other
mRNAs that encode tight junction proteins such as claudin-3,
claudin-4, ZO-1 and occludin. Instead, levels of tight junction-
specific mRNAs were significantly increased as a result of WNV
infection. For example, at 24 h post-infection, claudin-1 mRNA
levels were .1.8 fold higher than in mock-treated cells and at 72 h
post-infection, they were 3.9 times higher (p=0.039). Claudin-3
and claudin-4 mRNA levels steadily increased during WNV
infection and between 48 and 72 h, were as much as 2.2
(p=0.005) and 4.6 (p=0.043) fold higher respectively than mock
samples. Levels of JAM-1 and ZO-1 mRNAs also increased
significantly with peak expression levels observed at 48 h post-
infection. Accordingly, we conclude that WNV-induced loss of
specific tight junction membrane proteins results exclusively from
protein degradation. Moreover, it is likely that this process occurs
in all polarized cells regardless of whether they of epithelial or
endothelial origin.
Dynamin and microtubules are required for WNV-
induced degradation of claudin-1 and JAM-1
Having ruled out the possibility that WNV infection affects the
transcription and/or degradation of tight junction protein-
encoding mRNAs, we next focused on determining how virus
infection induces degradation of claudin-1 and JAM-1 proteins.
There are a number of ways in which integral membrane proteins
of the plasma membrane can be targeted for degradation, the most
common of which involves clathrin- or caveolae-dependent
endocytosis followed by lysosomal degradation. Moreover, be-
cause it has been reported that in response to various physiological
and pathological stimuli, tight junction barrier function can be
modulated by selective endocytosis of components such as claudins
[11,12,13], we elected to investigate this pathway first. Internal-
ization of plasma membrane proteins via clathrin-coated vesicles
or caveolae requires the action of the GTPase dynamin [14]. As
such, if WNV-induced degradation of tight junction membrane
proteins involves their removal from the cell surface by canonical
endocytic pathways, blocking dynamin function should inhibit the
turnover of claudin-1 and JAM-1 in infected cells. Indeed,
treatment of cells with the dynamin-specific inhibitor Dynasore
[15] completely protected these proteins from degradation during
viral infection (Figure 3).
Figure 1. WNV infection results in loss of claudin-1 and JAM-1 proteins in epithelial and endothelial cells. CACO-2 (A), MDCK (B), and
HUVEC (C) cells were infected with WNV for 48 hours after which cell lysates were subjected to immunoblot analyses with antibodies to WNV capsid
or NS3, claudin-1, JAM-1, occludin and b-actin. The ratios of the relative levels of tight junction proteins (compared to b-actin) from 3 independent
experiments were averaged and plotted. Error bars represent standard error of the mean.
doi:10.1371/journal.pone.0037886.g001
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of actin filaments and microtubules impact the stability of claudin-
1 and JAM-1 in WNV-infected cells. Many membrane trafficking
events in mammalian cells are dependent upon microtubules and
their associated motor proteins (reviewed in [16]), including
transport from endosomes to lysosomes [17]. Accordingly, drugs
such as nocodazole that inhibit formation of microtubules, should
protect claudin-1 and JAM-1 from WNV-induced degradation if
the pathway involves transport from endosomes to lysosomes. In
contrast to drugs that stabilize microtubules (paclitaxel) or inhibit
formation of actin filaments (latrunculin B), treatment of WNV-
infected cells with nocodazole completely blocked the degradation
of claudin-1 and JAM-1 (Figure 3).
Together, our data are consistent with a scenario in which
WNV infection causes dynamin-dependent endocytosis of claudin-
1 and JAM-1 followed by transport along microtubules en route to
endosomes/lysosomes. However, we cannot rule out the possibility
that viral infection causes misrouting of nascent claudin-1 and/or
JAM-1 to lysosomes. For example, the nef protein of human
immunodeficiency virus downregulates cell surface expression of
MHC 1 complexes by stimulating their endocytosis as well as
diversion of nascent MHC 1 complexes from the trans-Golgi
network to the lysomes [18]. Similar to endocytosis, trafficking of
proteins along this route is sensitive to nocodazole [19] and also
requires dynamin for vesicle scission from the trans-Golgi network
[20]. Therefore, to differentiate whether WNV infection induces
Figure 2. WNV infection leads to increased transcription of multiple tight junction genes. Total RNA extracted from mock and WNV-
infected CACO-2 cells at 24, 48 and 72 h post-infection was subjected to quantitative RT-PCR. The levels of tight junction protein encoding mRNAs
relative to GAPDH were determined using a comparative cT method. In the mock infected samples, values were normalized to 1.0 but are not shown
on the graph. The bars and associated values denominate the mean values, with one-fold standard deviations depicted in the high and low bars.
doi:10.1371/journal.pone.0037886.g002
Figure 3. WNV-induced degradation of claudin-1 and JAM-1 requires dynamin and microtubules. A. CACO-2 cells were infected with
WNV and 24 hours later were treated with nocodazole (10 mM), Dynasore (10 mM), paclitaxel (1 mM), latrunculin B (10 mM) or DMSO for a further
8 hours. The corresponding cell lysates then subjected to immunoblot analyses. B. Data from three independent experiments were used to
determine the normalized levels of claudin-1 and JAM-1 (relative to b-actin).
doi:10.1371/journal.pone.0037886.g003
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membrane or re-routing of nascent claudin-1 and JAM-1 from the
trans-Golgi network to the lysosomes, we monitored the localiza-
tion of these proteins in WNV infected cells that had been treated
with Dynasore or nocodazole. If WNV infection causes re-routing
of nascent claudin-1 from the trans-Golgi network to lysosomes
using a mechanism that requires dynamin activity and microtu-
bule-dependent transport, then treatment of infected cells with
Dynasore or nocodazole should result in their accumulation in the
trans-Golgi network and/or associated vesicles in the juxtanuclear
region. Based on the data shown in Figures 4 and 5, this does not
appear to be the case. When infected cells were treated with these
inhibitors, there was no significant build up of claudin-1 or JAM-1
in the juxtanuclear region but rather, we observed that the plasma
membrane localization of these proteins was preserved. Therefore,
we conclude that the primary mechanism by which WNV induces
turnover of tight junction membrane proteins is through dynamin-
dependent endocytosis followed by microtubule-dependent trans-
port to lysosomes.
Dengue virus infection does not affect tight junction
membrane proteins
DENV is a related flavivirus that is best known for the serious
hemorrhagic disease that it causes following mosquito-borne
transmission. Infection by DENV can result in vascular leakage
by affecting tight junction permeability through a process
involving cytokines [21]. For example, macrophage migration
inhibitory factor, which is secreted by virus-infected cells, can
directly affect tight junction permeability by activating MAP
kinase pathways or indirectly by inducing monocytes to secrete
tumor necrosis factor a (TNFa) and other cytokines that influence
the barrier function of endothelial cells. DENV has also been
shown to cause neuroinvasive disease which requires the virus to
breach the blood brain barrier (reviewed in [22]). In contrast to
WNV, DENV infection did not significantly alter the localization
tight junction membrane proteins such as claudin-1 (Figure 6A) or
JAM-1 (data not shown). A discernable reduction in claudin-1
protein levels (Figure 6B) was observed but this decrease was very
small compared to the loss of claudin-1 in WNV-infected cells.
Similarly, JAM-1 and occludin protein levels were not significantly
affected by DENV infection.
Expression of WNV capsid protein does not cause
degradation of tight junction membrane proteins
Finally, we endeavoured to understand how the WNV capsid
protein which was recently reported as the virus antigen that
disrupts tight junction barrier function [5], interacts with the
dynamin-dependent endocytosis machinery. As the first step in this
Figure 4. Internalization of claudin-1 is blocked by disrupting microtubules or inhibiting dynamin function. MDCK cells were infected
with WNV and 24 hours later were treated with 10 mM nocodazole, 10 mM Dynasore or DMSO for a further 8 hours. Samples were then processed for
indirect immunofluorescence using mouse anti-claudin-1 and rabbit anti-WNV capsid. Primary antibodies were detected using donkey anti-mouse
Alexa546 and donkey anti-rabbit Alexa488 secondary antibodies. Nuclei were counter stained with DAPI. Images were captured using a Leica TCS SP5
confocal scanning microscope. Size bars are 10 mm.
doi:10.1371/journal.pone.0037886.g004
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protein in the absence of other WNV proteins results in
degradation of claudin-1. For these experiments, we used lentiviral
pseudoparticles to transduce CACO-2 and MDCK cells with a
cassette encoding the mature form of WNV capsid protein. In
contrast to Medigeshi et al [5], we did not observe significant
degradation of claudin-1 or JAM-1 in capsid-expressing cells
(Figure 7A, B), nor was there any appreciable loss of tight junction
membrane proteins from the cell surface (Figure 8). We also
examined if capsid interacts with claudin-1 and/or JAM-1 in
WNV-infected cells. Data from reciprocal co-immunoprecipita-
tion experiments indicate that capsid does not form a stable
complex with either of these proteins (Figure 7C). Moreover,
consistent with what was observed in WNV-infected cells,
significant colocalization between capsid and claudin-1 or JAM-
1 in the transduced cells was not evident (Figure 8).
Discussion
Tight junctions are highly dynamic structures whose organiza-
tion can be altered in response to physiological and pathological
situations. With respect to the latter, it is evident that the
pathogenic effects of many viruses are due to loss of tight junction
barrier function. Indeed, disruption of these structures is associated
viral spread, circulation shock and infiltration of immune cells into
compartments such as alveolar space and the central nervous
system. Interestingly, there are a wide variety of mechanisms by
which viruses can negatively impact tight junctions. For example,
the E protein of the severe acute respiratory syndrome coronavirus
interferes with lung epithelial tight junction assembly by binding to
the PDZ domain of PALS1 [2]. Similarly, NS1 proteins from
highly virulent strains of avian influenza virus bind and sequester
PDZ domain-containing proteins such Scribble and Dlg1, MAGI-
1, MAGI-2 and MAGI-3 resulting in their mislocalization from
tight junctions [3]. As well as allowing influenza viruses to cross the
epithelium, loss of tight junction barrier function is a major
underlying factor in pulmonary edema. The examples cited above
involve scenarios in which virus replication and expression of viral
proteins are required for interfering with tight junctions. In
contrast, the lethal circulation shock caused by Ebola virus may
occur in the absence of virus replication or interaction of virus
proteins with host cells. Disruption of tight junctions in this case
may be due to binding of virus particles to endothelial cells which
in turn activates them resulting in loss of barrier function [4].
To cause systemic infections and gain access to the central
nervous system, WNV must cross epithelial and endothelial cell
layers after arthropod-mediated transmission. There are numerous
reports indicating that WNV infection compromises the integrity
of the blood brain barrier [6,7,8,23] and collectively, these data
suggest that both viral and host factors are involved. With respect
to the latter, WNV infection induces expression of matrix
Figure 5. Internalization of JAM-1 is blocked by disrupting microtubules or inhibiting dynamin function. MDCK cells were infected with
WNV and 24 hours later were treated with 10 mM nocodazole, 10 mM Dynasore or DMSO for a further 8 hours. Samples were then processed for
indirect immunofluorescence using rabbit anti-JAM-1 and mouse anti-WNV NS3/2B. Primary antibodies were detected using donkey anti-mouse
Alexa546 and donkey anti-rabbit Alexa488 secondary antibodies. Nuclei were counter stained with DAPI. Images were captured using a Leica TCS SP5
confocal scanning microscope. Size bars are 10 mm.
doi:10.1371/journal.pone.0037886.g005
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for viral infection of the central nervous system [8]. One theory is
that MMP9 compromises the blood brain barrier by degrading the
extracellular matrix. This scenario does not rule out virus-
mediated effects on tight junctions nor transcytosis as being
important for crossing this barrier because once the virus breaches
the endothelium, it must still traverse the extracellular matrix
before it can access the central nervous system. Immunomodula-
tory cytokines are also thought to play a role in WNV
neuroinvasion. For example, WNV infection of immune cells
results in secretion of TNFa which dampens viral replication in
peripheral tissues [24]. However, this anti-viral cytokine also
induces endocytosis of the tight junction membrane protein
occludin [25] which may inadvertently facilitate transmission of
the virus across the blood brain barrier. Similarly, cytokines
released from DENV-infected cells can directly or indirectly
influence the permeability of endothelial tight junction complexes
[21,22].
While it is clear that flavivirus infection can negatively impact
tight junctions, there is controversy as to whether or not they
directly affect the expression and/or degradation of tight junction
proteins. In the present study, we report for the first time, the
results from a carefully controlled and coordinated study on the
effects of WNV infection on tight junction membrane proteins in
both epithelial and endothelial cells. Our results are in partial
agreement with Medigeshi et al in that WNV infection results in
degradation of claudin-1 protein but not occludin or ZO-1.
Moreover, we observed that infection of endothelial cells
(HUVECs) results in loss of claudin-1 and JAM-1 proteins. While
we cannot reconcile the result of Verma et al. who did not observe
loss of tight junction proteins in WNV-infected human brain
microvascular endothelial cells, our present results and those of
Medigeshi et al. indicate that viral infection induces loss of tight
junction membrane proteins in both epithelial and endothelial
cells.
Unlike Medigeshi et al however, we saw no evidence that
expression of capsid protein alone affected levels of claudin-1 (or
JAM-1); despite the fact that in both studies, capsid protein from
the NY99 strain of WNV was employed. The apparent
discrepancy in our results may be related to the fact that different
expression systems were employed. Whereas Medigeshi et al used
stably transfected cells expressing capsid protein for their
experiments, we used lentiviral transduction to induce robust
transient expression of capsid in cells which arguably, more closely
parallels the expression kinetics of capsid protein in WNV-infected
cells. Co-immunoprecipitation experiments failed to detect inter-
action between capsid and tight junction membrane proteins nor
did we observe significant localization between these proteins and
capsid in infected cells. Thus it seems unlikely that capsid protein is
directly involved in targeting claudin-1 or JAM-1 to lysosomes.
Upon closer examination of the data from Medigeshi et al,w e
noticed that some claudin protein degradation occurred when
epithelial cells were infected with subviral particles that lack the
capsid gene, an observation which was attributed to the possibility
that there was sufficient residual capsid protein in the virus
particles to induce claudin degradation or that a redundant,
Figure 6. DENV infection does not affect tight junctions. A. MDCK cells were infected with DENV-2 and after 48 hours, samples were
processed for indirect immunofluorescence using human anti-DENV serum and mouse anti-claudin-1. The human serum recognizes DENV structural
proteins (DENV SP). Primary antibodies were detected using donkey anti-human Texas Red and donkey anti-mouse Alexa488 secondary antibodies.
Nuclei were counter stained with DAPI. Images were captured using a Leica TCS SP5 confocal scanning microscope. Size bars are 10 mm. B. CACO2
cells were infected with DENV-2 and after 48 hours, relative levels of claudin-1, JAM-1, and occudin were determined by immunoblotting. DENV
capsid protein was detected using a guinea pig polyclonal antibody and b-actin was detected using a mouse monoclonal antibody. Data from 3
independent experiments were averaged and plotted. Bars indicate standard error of the mean.
doi:10.1371/journal.pone.0037886.g006
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[5]. These scenarios seem unlikely to us, however, it cannot be
ruled out that capsid protein is required, but not sufficient for
degradation of tight junction membrane proteins in WNV-infected
cells.
Collectively, our data suggest that the primary mechanism for
loss of claudin-1 and JAM-1 in WNV-infected cells involves
endocytosis from the cell surface. Because capsid protein does not
appear to be physically involved in this process, we hypothesize
that WNV replication and/or assembly triggers a signalling event
that leads to endocytosis of a subset of tight junction membrane
proteins. Endocytosis of these proteins is in fact a normal process
that is used to regulate the permeability of tight junctions in
response to physiological stimuli [1]. For example, inflammatory
cytokines such as TNFa induce caveolae-dependent endocytosis of
occludin [25]. Even though cytokine expression and secretion is a
common cellular response to virus infection, it is unlikely that this
is the primary mechanism by which WNV induces lysosomal
degradation of selected tight junction membrane proteins in
epithelial cells at least. First, we are unaware of any data showing
that WNV infection of MDCK and CACO-2 cells results in
production of proinflammatory cytokines. Moreover, infection of
these cells with other RNA viruses does not significantly affect
production of cytokines such as TNFa and interleukins [26,27].
Second, while treatment of CACO-2 cells with TNFa or IL-1b
can lead to tight junction failure through degradation of occludin
and possibly other mechanisms [28], exposure to IL-1b actually
increases levels of claudin-1 [29]. In contrast, we observed that in
WNV-infected epithelial cells, occludin levels remain stable while
claudin-1 and JAM-1 protein levels are significantly lower.
In summary, it is likely that WNV employs multiple strategies to
cross polarized cell layers. These include; stimulating endocytosis
and degradation of key transmembrane proteins of the tight
junction; inducing production of matrix metalloproteases that
degrade basement membranes; stimulating immune cells and
possibly endothelial cells to secrete proinflammatory cytokines that
disrupt tight junctions. A clearer understanding how WNV causes
these events may lead to therapeutic treatments that block viral
spread or design of attenuated vaccine strains.
Materials and Methods
Reagents and antibodies
The following reagents were purchased from the respective
suppliers: protein A-sepharose, protein G-sepharose from GE
Healthcare Bio-Sciences AB (Piscataway, NJ); general lab chem-
icals, DMSO, Nocodazole, Dynasore, Paclitaxel and Latrunculin
B from Sigma-Aldrich (St. Louis, MO); Complete
TM EDTA-free
protease inhibitor cocktail, FuGENE 6 transfection regent from
Roche Diagnostics (Laval, Quebec); ProLongH Gold Antifade
reagent with 49-6-diamidino-2-phenylindole (DAPI), media and
fetal bovine serum (FBS) for cell culture from Invitrogen; Pierce
BCA Protein Assay Kit from Thermo Scientific (Rockford, IL);
High Capacity RNA-to-cDNA Master Mix and Fast SYBR Green
Master Mix from Applied Biosystems (Streetsville, ON); qScript
One-Step SYBR Green qRT-PCR Kit from Quanta Biosciences
(Gaithersville, MD); HEK-293T, CACO-2 and MDCK cells from
the American Type Culture Collection (Manassas, VA). Human
umbilical vein endothelial cells (HUVECs) isolated from individual
umbilical cords as described [30] were obtained from Dr. Denise
Hemmings (Obstetrics & Gynaecology, University of Alberta).
These primary cells were used for experiments between passages
2–6.
The following primary antibodies were obtained from the
following sources: claudin-1 specific mouse monoclonal antibodies
used respectively for immunoprecipitation/immunoblotting and
indirect immunofluorescence were from Invitrogen (Carlsbad, CA)
and Santa Cruz Biotechnology (Santa Cruz, CA); mouse
monoclonal antibodies to b-actin from Abcam (Cambridge,
MA); rabbit and guinea pig polyclonal antibodies to WNV capsid
protein were generated in this laboratory [10,31]; rabbit
polyclonal antibody to JAM-1 and mouse monoclonal to occludin
from Invitrogen (Carlsbad, CA); mouse monoclonal antibodies
against West Nile virus proteins NS3/2B from and R&D Systems
(Minneapolis, MN); rabbit polyclonal antibody to green fluores-
cent protein (GFP) was from Dr. L. Berthiaume (University of
Alberta, Edmonton, Canada). Pooled human anti-dengue virus
(DENV)-2 convalescent sera [32] was kindly provided by Dr.
Robert Anderson (Dalhousie University, Halifax, Canada). Poly-
clonal antibodies to DENV-2 capsid protein were obtained by
immunization of guinea pigs (Pocono Rabbit Farm & Laboratory,
Canadensis, PA) with a synthetic peptide corresponding to the 20
amino terminal amino acid residues of capsid protein coupled to
keyhole limpet hemocyanin.
The following secondary antibodies were obtained from the
following sources: Donkey anti-human IgG conjugated to Texas
Red, goat anti-rabbit and goat anti-mouse IgG conjugated to
horseradish peroxidase (Jackson ImmunoResearch Laboratories,
West Grove, PA); Donkey anti-rabbit IgG conjugated to Alexa488
and Donkey anti-rabbit IgG conjugated to Alexa647, donkey anti-
mouse IgG conjugated to Alexa546 or Alexa488, goat anti-guinea
pig IgG conjugated to Alexa546, donkey anti-mouse conjugated to
Alexa680 and donkey anti-rabbit conjugated to Alexa800 (In-
vitrogen, Carlsbad, CA).
Cell culture and virus infection
CACO-2, MDCK and HEK293T cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) containing 10%
heat-inactivated FBS, 4.5 g/liter D-glucose, 2 mM glutamine,
25 mM HEPES, 110 mg/liter sodium pyruvate, 1% penicillin-
streptomycin. HUVECs were cultured in M199 containing Earle’s
salts, 10% heat-inactivated FBS, L-glutamine, NaHCO3, 1%
penicillin-streptomycin plus 1% of endothelial cell growth
supplement.
WNV strain NY99 and DENV-2 were kindly provided by Dr.
Mike Drebot at the Public Health Agency of Canada (Winnipeg,
MB, Canada). WNV manipulation was performed in the Glaxo
CL-3 facility (University of Alberta) and DENV was handled
under CL-2 conditions.
Unless otherwise indicated, cells were infected with viruses at
multiplicity of infection (MOI) of 5. MDCK cells grown on
coverslips or in p35 dishes were infected with WNV for 48 h and
then processed for indirect immunofluorescence or co-immuno-
Figure 7. Expression of capsid in the absence of other WNV proteins does not cause degradation of tight junction proteins. CACO-2
(A) and MDCK (B) cells were infected with WNV or transduced with lentiviruses encoding GFP alone (Vector) or GFP and WNV capsid (Capsid). Forty
eight hours post-infection/transduction, lysates were subjected to immunoblot analyses. Data from three independent experiments were used to
determine the normalized level (to b-actin) of claudin-1, JAM-1, occludin in each sample. C. MDCK cells were infected with WNV and 48 hours later,
lysates were subjected to immunoprecipitation (IP) with rabbit anti-capsid, anti-JAM-1 or mouse anti-claudin-1 antibodies followed by
immunoblotting with antibodies to claudin-1, JAM-1 or capsid. WCL=whole cell lysate.
doi:10.1371/journal.pone.0037886.g007
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MDCK or CACO-2 cell cultures were treated with nocodazole
(10 mM), Dynasore (10 mM), Paclitaxel (1 mM) or Latrunculin B
(10 mM). The drugs were added at 24 h post infection and the cells
were incubated for 8 h before processing for immunoblot or
indirect immunofluorescence analyses.
HUVEC were passaged in 0.2% gelatin-coated 25 cm
2 flasks.
For infection experiments, cells (4610
5) were seeded in gelatin-
coated p35 dishes and allowed to attach overnight. The next day,
medium was replaced with 0.5 ml of WNV stock diluted in serum-
free M199 medium for 1 h after which the virus was removed.
Cells were then washed twice with PBS before fresh growth
medium was then added. Infected HUVECs were analyzed
between 2–72 h post-infection.
Preparation and use of lentiviruses encoding WNV capsid
A PCR-generated WNV capsid cDNA was subcloned into the
SpeI and XhoI sites of the plasmid pTRIP-CMV-MCS-IRES-
AcGFP; which was derived by replacing the red fluorescent
protein cassette of pTRIP-CMV-IRES-tagRFP [33] with AcGFP
using NheI and SacII. The resulting plasmid pTRIP-IRES-AcGFP-
Cap, directs independent expression of AcGFP and capsid. To
produce infectious lentiviral pseudoparticles, HEK293T cells
(2.5610
6) grown in 100 mm-diameter dishes were co-transfected
with pTRIP-IRES-AcGFP-Cap (5.6 mg) or pTRIP-IRES-AcGFP
(5.6 mg), pGag-Pol (5.6 mg) and pHCMV-VSVG (1.6 mg) [33]
using Fugene 6 transfection reagent. Forty eight hours later,
polybrene (4 mg/ml) and HEPES (20 mM) were added to
harvested lentivirus-containing cell culture supernatants which
were then passed through 0.45 mm filter, aliquotted and then
stored at 280uC or used to transduced CACO-2 or MDCK cells
in 6 well dishes. Typically, lentiviral stocks were diluted 1:10 in
DMEM containing 3% FBS, polybrene (4 mg/ml polybrene) and
HEPES (20 mM). Cells were then spinoculated by centrifugation
at 1200 rpm in an Eppendorf A-4-62 rotor for 1 h at 37uC after
which the plates were transferred to a 37uC incubator. After 6 h,
the media were replaced with DMEM containing 10% FBS.
Unless otherwise indicated, transduced cells were analyzed 48 h
post-transduction.
Immunoblotting
Virus-infected or lentivirus-transduced cells were washed twice
with cold PBS on ice, then lysed in RIPA buffer (50 mM Tris-HCl
[pH 7.4], 150 mM NaCl, 1% Triton x-100, 1% sodium deoxy-
cholate, 0.1% sodium dodecylsulfate [SDS], 1 mM EDTA)
containing a cocktail of protease inhibitors. Cell lysates were
incubated on ice for 30 min and then centrifuged at 12,0006g for
15 min at 4uC after which protein concentrations in the
supernatants were quantified by BCA assay. Equivalent amounts
of proteins (20 mg/sample) were resolved by SDS-PAGE, trans-
ferred to immobilon-polyvinylidene fluoride (PVDF) membranes
and then detected by immunoblotting. Quantification of the
proteins detected in the immunoblots using fluorescently tagged
secondary antibodies was performed by using a Licor Odyssey
Infrared Imaging System (Lincoln, NE) using the protocol posted
at http://biosupport.licor.com. Relative levels of claudin-1, JAM-
1 and occludin (normalized to b-actin) were determined using
Odyssey Infrared Imaging System 1.2 Version software.
Indirect immunofluorescence
MDCK and CACO-2 cells grown on coverslips were processed
for indirect immunofluorescence microscopy 48 h after infection
with WNV or transduction with the lentiviral vector. Cells were
washed twice in PBS containing 0.5 mM Ca
2+ and 1.0 mM Mg
2+
Figure 8. Capsid expression does not result in redistribution of
claudin-1 or JAM-1. MDCK cells were transduced with vector or
capsid-expressing lentiviruses and at 48 hour post transduction, were
processed for indirect immunofluorescence using mouse anti-claudin-1,
mouse anti-occludin, rabbit anti-JAM-1, and rabbit or guinea pig anti-
WNV capsid. Primary antibodies were detected using donkey anti-
mouse Alexa546, donkey anti-rabbit Alexa647, and goat anti-guinea pig
Alexa546 secondary antibodies. Nuclei were counter stained with DAPI.
Images were captured using a Leica TCS SP5 confocal scanning
microscope. Size bar=10 mm.
doi:10.1371/journal.pone.0037886.g008
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Samples were quenched with PBS containing 50 mM ammonium
chloride and then washed twice with PBSCM. Cell membranes
were permeabilized with PBS containing 0.2% Triton X-100 for
5 min and then nonspecific antibody binding sites were blocked by
incubating with PBSCM solution containing 1% BSA for 30 min
at room temperature (RT). For samples that were stained with
rabbit anti-JAM-1, cells were fixed with ethanol at 4uC for
30 minutes followed by treatment with cold acetone for 5 minutes
at RT. Fixed cells were washed three times, followed by incubation
with pooled human anti-DENV sera (1:2500), mouse anti-claudin-
1 (1:300), (Santa Cruz), mouse anti-occludin (1:300), rabbit anti-
JAM-1 (1:300), mouse anti-NS3/2B (1:500) and/or rabbit anti-
WNV capsid (1:300) for 2 h at RT. Primary antibodies were
detected with Alexa Fluor 546-conjugated Donkey anti-mouse,
Alexa Fluor 647-conjugated donkey anti-rabbit, Alexa Fluor 488-
conjugated donkey anti-rabbit secondary antibodies for 1 h at RT.
Coverslips were mounted onto microscope slides using ProLongH
Gold Antifade containing DAPI and samples were examined using
a Leica TCS SP5 confocal microscope. Captured images were
processed using Image J and LAS AF Lite softwares.
Co-immunoprecipitation
MDCK cells (3610
5) seeded into P35 dishes, were infected the
next day with WNV. After 48 hours, the cells were washed twice
with cold PBS and then lysed with NP-40 lysis buffer (150 mM
NaCl, 2 mM EDTA, 1% Nonidet P-40, 50 mM Tris-HCl
[pH 7.2], 1 mM fresh dithiothreitol) containing protease inhibitors
on ice for 30 min. Lysates were clarified by centrifugation for
15 min at 12,0006g in a microcentrifuge at 4uC. Small aliquots of
the clarified lysates were kept for loading controls. The remaining
lysates were pre-cleared with protein G-Sepharose or protein A-
Sepharose beads for 1 h at 4uC before sequential incubation with
mouse anti-claudin-1 or rabbit anti-capsid or JAM-1 antibodies for
3 h and then protein G-Sepharose beads or protein A-Sepharose
beads for 2 h at 4uC. Immunoprecipitates were washed three times
with lysis buffer before the bound proteins were eluted by boiling
in protein sample buffer. Proteins were separated by SDS-PAGE
and transferred to PVDF membranes for immunoblotting.
Quantitative PCR analysis
Expression of junction protein genes in WNV-infected CACO-2
cells was measured using quantitative RT-PCR of total RNA.
Data was obtained using RNA extracted from two batches of
independently infected cells. Total RNA from WNV-infected cells
harvested at 24 h, 48 h and 72 h post-infection was isolated with
TRI ReagentH (Ambion). RNA samples were adjusted to 100 ng/
ml by dilution in sterile RNAse/DNAse free water. Relative levels
of claudin-1, claudin-3, claudin-4, JAM1, ZO-1 and occludin
mRNAs as well as WNV genomic RNA were determined using
primers listed in Table 1. All genes of interest were analysed in a
two-step as well as in a one-step reverse transcriptase (RT-) PCR
approach.
In the two-step reaction setup, cDNA was generated from
500 ng of RNA (5 ml of diluted total RNA) using High Capacity
RNA-to-cDNA Master Mix (Applied Biosystems, Streetsville, ON)
with random primers in a reaction volume of 20 ml. Reaction
conditions were 5 min at 25uC, 30 min at 42uC and 5 min at
85uC. The resulting cDNA was diluted 1/10 in RNase free water,
of which 5 ml was used for subsequent DNA amplification. The
amplification was conducted with Fast SYBR Green Master Mix
(Applied Biosystems, Streetsville, ON) in a reaction volume of
25 ml. Primer concentration was 10 pmol. Reaction conditions
used were: 95uC for 30 sec, followed by 40 cycles of 95uC for 5 sec
and 55–60uC for 30 sec (temperature for annealing/extension step
dependent on primer Tm (Table 1)).
One-step reactions were performed in 25 ml volumes using
qScript One-Step SYBR Green qRT-PCR Kit (Quanta Biosci-
ences, Gaithersville, MD) starting with 100 ng of total RNA.
Primer concentration was 10 pmol. Reaction conditions were:
50uC for 10 min, 95uC for 5 min, followed by 40 cycles of 95uC
for 10 sec, 55–60uC for 20 sec and 72uC for 30 sec.
Formation of primer dimers and other unspecific products was
monitored by melt curve analysis (from 55uCt o9 5 uC). Relative
quantification of gene expression and successive calculation of
fold-increase of gene expression of tight junction mRNAs were
normalized to GAPDH mRNA levels using the comparative cT
(DDcT) method [34] All experiments were conducted in triplicates,
resulting in a minimum of eight data points for each gene of
interest. All gene expression studies were conducted on a CFX96
(Bio-Rad, Hercules, CA) or an Mx3005P (Stratagene, LaJolla, CA)
thermocycler. Statistical analysis on the data was conducted with
SPSS Statistics 17.0 software (SPSS Inc. Chicago, IL). Significant
variance of mRNA expression at 24, 48 and 72 h post infection
was evaluated using Tamhane’s T2 multiple comparison.
Table 1. List of Oligonucleotide Primers.
Primer Sequence
Tm
(6C)* Reference
Claudin-1
Forward
CCAACGCGGGGCTGCAGCT 55 [35]
Claudin-1
Reverse
TTGTTTTTCGGGGACAGGA 44
Claudin-3
Forward
CTGCTCTGCTGCTCGTGTCC 53 [36]
Claudin-3
Reverse
TTAGACGTAGTCCTTGCGGTCGTAG 54
Claudin-4
Forward
GGCTGCTTTGCTGCAACTGTC 51 [36]
Claudin-4
Reverse
GAGCCGTGGCACCTT ACACG 53
Occludin
Forward
TCAAACCGAATCATTATGCACCA 47 [36]
Occludin
Reverse
AGATGGCAATGCACATCACAA 45
JAM1
Forward
ACCAAGGAGACACCACCAGAC 51
JAM1
Reverse
GAGGCACAAGCACGATGAGC 51
ZO-1
Forward
CAAGATAGTTTGGCAGCAAGAGATG 51 [37]
ZO-1
Reverse
ATCAGGGACATTCAATAGCGTAGC 51
GAPDH
Forward
GAAATCCCATCACCATCTTCCAGG 52
GAPDH
Reverse
GAGCCCCAGCCTTCTCCATG 53
WNV
Forward
TCTGCGGAGAGTGCAGTCTGCGAT 56 [38]
WNV
Reverse
TCAGCGATCTCTCTC CACCAAAG 52
*adjusted for 50 mM salt concentration.
doi:10.1371/journal.pone.0037886.t001
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